How Biden’s Antitrust Fight Could Play Out Under Trump
Experts suggest Trump would be open to more corporate mergers and deals than the Biden administration...
Archive for November 2024
Read More »
Qiana Volkman
03:20
The ultimate steampunk machine? Toshiba glued an old-school dot matrix printer with a DVD drive, a touchscreen display and a PC with two SSDs — and it even runs Windows 10
Toshiba’s Jimucon SJ-9500 office computer combines a whole load of random features into a Frankenstein PC...
Erasmo Pecora
03:19
After iPhone and iMac, Apple may be courting Foxconn to build AI servers based on its M-series CPU to accelerate Apple Intelligence potential
Apple "courting" Foxconn to build AI servers based on its M-series CPU to accelerate Apple Intelligence potential...
Tomi Redner
03:19
Gemini is coming to supercharge Google Assistant on smart displays and speakers – and here’s how it will work
Google Assistant is continuing its work on Nest devices, but Gemini is going to be lending a helping hand...
Anthony Ramage
03:19
Melting Glaciers Are Causing Billions of Dollars of Damage
Thawing ice, from the high peaks to the poles, is producing extraordinarily expensive floods, infrastructure damage and losses to tourism
Erasmo Badon
03:19
AI Analysis of Police Body Camera Videos Reveals What Typically Happens during Traffic Stops
Examining body camera videos at scale reveals racial differences in how police treat drivers during traffic stops—and what corrective programs
Diego Schildgen
03:19
The U.S. Must Lead the Global Fight against Superbugs
Antimicrobial resistance could claim 39 million lives by 2050, yet the pipeline for new antibiotics is drying up. U.S. policy
Margherita Serna
03:19
AI Can Do Whole Echo Reports, Improve Efficiency
MedPage Today) -- CHICAGO -- Artificial intelligence (AI) assistance for echocardiography is becoming better validated and proving mettle for clinical
Maribel Stoval
03:19
Spironolactone Misses the Mark in Acute MI Without HF
MedPage Today) -- CHICAGO -- A mineralocorticoid receptor antagonist (MRA) was unable to further improve 3-year outcomes of acute myocardial
Elroy Kucera
03:19
Is DOAC A Viable Option After Bioprosthetic Valve Surgery Even in Sinus Rhythm?
MedPage Today) -- CHICAGO -- Edoxaban (Savaysa) appeared at least on par with warfarin for 12-week thromboembolic prophylaxis after bioprosthetic
